1. 53P Combining cancer vaccines based on arenavirus vectors with 4-1BB (CD137) agonists enhances therapeutic efficacy in a non-inflamed tumor model. (December 2022) Authors: Strauss, J.; Reckendorfer, D.; Pojar, K.; Pölzlbauer, T.; Habbeddine, M.; Scheinost, M.; Ahmadi-Erber, S.; Schmidt, S.; Raguz, J.; Lampert, J.C.; Orlinger, K.K.; Lauterbach, H. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗